While supporters and opponents of President Obama’s healthcare reform legislation let out boos or cheers for the recent decision of the United States Supreme Court, one industry will not be pleased, according to Kalorama Information. The healthcare market research publisher says that the medical device industry will face additional costs
Generation Opportunity President Paul T. Conway Statement: Scotus Health Care Decision's Impact on Young AmericansJune 28, 2012 2:19 pm | News | Comments
Generation Opportunity President Paul T. Conway, former Chief of Staff for the US Department of Labor and former Deputy Secretary of Health and Human Resources for the Commonwealth of Virginia, has issued the following statement regarding the Supreme Court's decision today on the Patient Protection and Affordable Care Act:
With the U.S. Supreme Court ruling upholding the constitutionality of the Affordable Care Act (ACA), Cook Medical now calls for the U.S. Senate to repeal the 2.3 percent medical device excise tax included in that legislation.
EndoGastric Solutions Announces Second Randomized Controlled Trial Comparing TIF Procedure to PPI Therapy for the Treatment of GERDJune 28, 2012 2:02 pm | News | Comments
EndoGastric Solutions® (EGS), the leader in endoluminal treatment of Gastroesophageal Reflux Disease (GERD), today announced the start of the TIF versus Medical Proton Pump Inhibitor (PPI) Management of Refractory GERD Symptoms (TEMPO) trial. TEMPO, the second in a series of randomized trials involving TIF, is designed to assess the safety and efficacy of the procedure—performed using EndoGastric Solutions’ EsophyX® device—as compared to PPI therapy to treat bothersome symptoms associated with chronic GERD.
NLT SPINE Reports Positive Clinical Results for PROW FUSION, Its Lumbar Interbody Fusion Device for Minimally Invasive Spine SurgeryJune 28, 2012 1:57 pm | News | Comments
NLT SPINE, a developer of products for Minimally Invasive Spine Surgery (MISS) and percutaneous procedures, announced today that initial results from clinical experience with its PROW FUSION device are highly positive.
American Heart Association CEO Nancy Brown issued the following statement today on the U.S. Supreme Court's ruling upholding the Affordable Care Act: "The historic decision handed down today will benefit America's heart health for decades to come. Questions about the Affordable Care Act's constitutionality have overshadowed the law's progress. With this ruling, that uncertainty has finally been put to rest.
Healthcare Supply Chain Association (HSCA) President Curtis Rooney today released the following statement regarding the Supreme Court’s decision to uphold the Affordable Care Act: "Now that the Supreme Court has rendered its decision on the Affordable Care Act and the national conversation can return to healthcare reform centered on cost containment, hospitals and healthcare providers will rely more than ever on the billions of savings that their group purchasing organizations (GPOs) provide every year.
Following is a statement from John C. Lechleiter, Ph.D., chairman, president, and chief executive officer of Eli Lilly and Company, regarding today's U.S. Supreme Court ruling to uphold the Affordable Care Act: "Following today's decision by the U.S. Supreme Court on the Affordable Care Act,...
How are you influencing cardiovascular devices?
Cefepime:Label Change- Risk of Seizure in Patients Not Receiving Dosage Adjustments for Kidney ImpairmentJune 26, 2012 11:30 am | by U.S. Food & Drug Administration | News | Comments
Health care professionals should adjust the dosage of cefepime in patients with creatinine clearance less than or equal to 60 mL/min.
Ultrasonix Medical Corporation has received approval from the US Food and Drug Administration for its SonixGPS technology for Vascular Access procedures.
With the University of Pittsburgh’s development of a cell-free, biodegradable artery graft comes a potentially transformative change in coronary artery bypass surgeries: Within 90 days after surgery, the patient will have a regenerated artery...
Clinical investigators are for the first time examining the retrograde tibiopedal interventional approach, an endovascular technique that has the potential to reduce the rate of leg amputations by as much as 50 percent in patients with critical limb ischemia...
Johns Hopkins researchers have discovered that a single protein molecule may hold the key to turning cardiac stem cells into blood vessels or muscle tissue, a finding that may lead to better ways to treat heart attack patients.
Epilepsy Organizations Award Funding for New Devices to Treat, Detect, and Monitor Epilepsy ConditionsJune 25, 2012 6:45 am | News | Comments
The Epilepsy Therapy Project (ETP) and the Epilepsy Foundation (EF) today announced the latest grant recipients of their New Therapy Grants Program, a unique joint venture of the two non-profit epilepsy organizations to advance clinical development...
Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced the launch of its Nellcor™ SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform.
GE Extends Strategic Relationship With Australian-based Nanosonics to Expand Healthcare Innovation GloballyJune 24, 2012 8:18 pm | by The Associated Press | News | Comments
SYDNEY--(BUSINESS WIRE)--Jun 24, 2012-- GE [NYSE: GE] today announced a $7.5 million investment in Australian-based Nanosonics Limited [ASX: NAN] - a leader in the development of innovative technology for infection control - to further develop and distribute Trophon EPR, an ultrasound...
GE Extends Strategic Relationship With Australian-based Nanosonics to Expand Healthcare Innovation GloballyJune 24, 2012 4:45 pm | by The Associated Press | News | Comments
GE Extends Strategic Relationship With Australian-based Nanosonics to Expand Healthcare Innovation Globally SYDNEY--(BUSINESS WIRE)--Jun 24, 2012-- GE [NYSE: GE] today announced a $7.5 million investment in Australian-based Nanosonics Limited [ASX: NAN] - a leader in the development of...
A new memorandum issued by the U.S. Office of Special Counsel (OSC) instructing federal agencies to ensure their electronic surveillance policies and practices do not deter whistleblowing “confirms” the FDA broke the law when it allegedly monitored the personal emails of...
The House Wednesday overwhelmingly approved reauthorizing the Medical Device User Fee Act (MDUFA), sending it on to the Senate with a voice vote.
Nidek Medical Products Mark 5 Nuvo, Nuvo 8, and Nuvo Lite Oxygen Concentrators: Class I Recall - Risk of Fire, Loss of Supplemental OxygenJune 21, 2012 12:30 pm | by U.S. Food & Drug Administration | News | Comments
A capacitor failure may result in a fire hazard and loss of supplemental oxygen, which can lead to serious adverse health consequences, including death.
Class I Medical Device Recall: Nidek Medical Products, Inc., Mark 5 Nuvo, Nuvo 8 and Nuvo Lite Oxygen ConcentratorsJune 21, 2012 11:30 am | by U.S. Food & Drug Administration | News | Comments
Reason for Recall: Capacitor failure may result in a fire hazard and loss of supplemental oxygen. These products may cause serious adverse health consequences, including death.
Labeling, Approval Order, and Summary of Safety and Effectiveness for Access® Hybritech p2PSA on the Access Immunoassay Systems (P090026).
The Access® Hybritech p2PSA on the Access Immunoassay Systems is an automated laboratory test that measures how much [-2]proPSA a man has in his blood.
Integra LifeSciences Announces Launch of the Integra IPP-ON PIP Fusion System for Extremity ReconstructionJune 20, 2012 8:18 am | News | Comments
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of Integra(R) IPP-ON(R) PIP Fusion System, for fixation of proximal interphalangeal (PIP) joint arthrodesis.